Coronavirus

Bayer to support Harvard Research Study to Evaluate Trust in Science, Including in COVID-19 pandemic

Bayer to donate one million tablets of chloroquine for use in Italy

Added by AIFA along with other drugs to the list of medicines for off-label use against COVID-19

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments

Investigation of combination therapies including Bayer’s chloroquine and interferon beta-1b to foster much needed solutions for patients in fight against coronavirus pandemic / Bayer Canada to make CAD 1.5 million (approximately 1 million euros) financial commitment and to supply products in support of the research / Plans to include more than 60 contributing research locations involving 6.000 patients

Bayer to donate EUR 1 million to support the fight against COVID-19 in Brazil

Support for projects of the Brazilian government, the national health system and UNICEF

Bayer to donate EUR 1 million to support the fight against the coronavirus pandemic in France

Money will help caregivers, patients and their families, and fund research / Bayer is supporting various further initiatives in France

Bayer donates 8 million chloroquine tablets to the German Federal Government

Additional donations of chloroquine sent to governments in numerous other countries / Various clinical and preclinical studies investigate the efficacy and adverse effects in COVID-19 infections / Bayer plans considerable expansion of production capacities in the event that the efficacy of chloroquine is proven for COVID-19

Bayer supports fight against the corona pandemic in Spain with measures totaling approximately 1 million euros

Bayer planning to hold online-only stockholders’ meeting on April 28, 2020

Stockholders able to exercise right to submit questions and cast votes in a timely manner / Online stockholders’ meeting enables proposed dividend of 2.80 euros per share for 2019 to be paid on time and in full / Baumann: “Reliability for our stockholders is very important, especially during the crisis”

Bayer to boost Germany’s COVID-19 analysis capacity by several thousand tests per day

Bayer donates one million euros for hospitals in Lombardy

Chairman of the Board of Management, Baumann: “Our emergency aid is designed to help support hospitals and hospital staff during the crisis.”

Bayer to donate medicines and money with a total value of approximately EUR 1.5 million

CEO Werner Baumann: “We want to help people in the affected regions quickly and effectively”